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The role of the cytoplasmic tail of the Moloney murine leukemia virus transmembrane protein in the regulation of syncytia
was examined. Three mutations within the cytoplasmic tail were studied. Linker-insertion in7705-12a is within the viral-
associated cytoplasmic tail, linker-insertion in7748-12a is within the R peptide, and a third mutation expresses TM lacking
the R peptide (Env R0). The Env R0 construct was nonviable in Rat1 cells, however, rapidly reverted to a form containing
the R peptide when passaged in NIH/3T3 cells. in7705-12a was temperature-sensitive in Rat1 cells, as previously character-
ized, but was viable at either temperature in NIH/3T3 cells. in7748-12a was comparable with wild-type M-MuLV. The ability
of the env constructs to form large multinucleated syncytia with NIH/3T3 and XC cells were examined using transient
expression assays, eliminating reversion events due to viral passage and reverse transcription. The Env R0 constructs
formed syncytia with NIH/3T3 cells. in7705-12a displays enhanced proteolytic cleavage of the R peptide. Neither linker-
insertion mutation in7705-12a or in7748-12a activated fusion with NIH/3T3, despite the abundance of processed TM with
in7705-12a. All three mutants were fusion competent with Rat XC cells, even in the absence of any cleavage of the R
peptide. These results provide insights regarding steric and the temporal affects of cleavage of the R peptide and the
assembly of a fusion competent oligomer. q 1997 Academic Press
INTRODUCTION in membrane fusion (Perez et al., 1987; Ragheb and An-
derson, 1994). The size and function of the cytoplasmic
In all retroviruses, the envelope proteins play a critical region varies in different retroviruses (Chakarabarti et al.,
role in the viral entry into the host cells. The env gene 1989; Dubay et al., 1992; Gallaher et al., 1989; Hunter
of Moloney Murine Leukemia Virus (M-MuLV) is initially and Swanstrom, 1990; Perez et al., 1987; Vzorov and
expressed as a precursor protein, which is proteolytically Compans, 1996). Virions which contain mutant MA pro-
cleaved to virion-associated surface protein (SU) and tein, encoded by the gag gene, interfere with the associa-
transmembrane protein (TM) (Hunter and Swantrom, tion of the Env proteins. In general, there is a correlation
1990). The TM protein (p15E) is processed further in the between this interference of envelope protein incorpora-
virus by the removal of 16 amino acids (R peptide) from tion onto viral particles and the size of the cytoplasmic
the carboxyl terminus to yield p12E (Green et al., 1981; tail of the Env protein (Freed and Martin, 1995; Freed
Karshin et al., 1977; Sutcliffe et al., 1980). The SU and and Martin, 1996). The cytoplasmic domain of MuLV’s
TM proteins are incorporated into the virus as hetero- are short; the M-MuLV virus consists of 32 amino acids.
polymers (Pinter and Fleissner, 1979). Mutations in the cytoplasmic region of M-MuLV TM pro-
TM is an integral membrane protein which anchors tein have been identified which affect the incorporation
SU on the virion surface and mediates the fusion of the of viral env proteins into viral particles (Granowitz et al.,
viral and cell membranes (Marsh and Helenius, 1989; 1991, 1996; Gray and Roth, 1993). Studies with truncated
McClure et al., 1990). The extracellular domain is in- TM reported the cytoplasmic tail is not required for Env
volved in the oligomerization of env (Einfeld and Hunter, transport and expression, but may interact with the viral
1988; Tucker, 1991; Li et al., 1996) and in the association core in a post membrane fusion step (Ragheb and Ander-
with SU by both covalent and noncovalent interactions son, 1994).
(Hunter and Swantrom, 1990; Pinter and Fleissner, 1977, Wild-type M-MuLV does not cause syncytia in NIH/
Thomas and Roth, 1995). The membrane spanning do- 3T3 cells. However, the virus is known to cause syncytia
main anchors the protein and is reported to be involved with varied conditions and cell lines. These include trans-
formed cells (Wilson et al., 1992), Rat XC cells (Rowe et
al., 1970), infection in the presence of amphotericin B1 Current address: Schering-Plough Research Institute, Kenilworth,
(Pinter et al., 1986), and mutations in either SU (Park etNew Jersey.
al., 1994) or TM (Ragheb and Anderson, 1994; Rein et2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 908-235-4783. E-mail: Roth@MBCL.Rutgers.Edu. al., 1994). Expression of a precursor SU/TM protein which
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lacks the R peptide activates membrane fusion and re- GCTCTATAGAATTCCGGCTGAAGCC, where the se-
quences in bold are M-MuLV. Plasmids pHIT123, pHIT60,sults in the production of syncytia in NIH/3T3 cells
(Ragheb and Anderson, 1994; Rein et al., 1994). Mutant and pHIT111 were a gift of Dr. Alan J. Kingsman. The
pHIT123 vector, expressing the ecotropic M-MuLV envvirus unable to cleave at the R peptide cleavage site had
diminished infectivity (Rein et al., 1994). Interestingly, the gene (Soneoka et al., 1995), was modified at the EcoRI
site by insertion of an NheI adapter (5* AATTGGCTAGCCM-MuLV R peptide is able to inhibit virus-induced cell
fusion when transferred to the cytoplasmic domain of the 3*). The M-MuLV env genes from Env R0, in7705-12a,
and in7748-12a were moved into the modified vector,SIV TM (Yang and Compans, 1996). These results imply
a regulatory role of the R peptide for envelope functions. pHIT123N, through a fragment exchange of the 2116-bp
PmlI/NheI fragment, generating pHITEnv R0, pHIT7705-R peptide processing is not to completion and wild-type
virions contain a mixture of p15E and p12E proteins (Hen- 12a, and pHIT7748-12a, respectively.
derson et al., 1984).
Previously, we have generated two linker insertion mu- RESULTS
tants in the cytoplasmic domain of M-MuLV TM (Gray
Previous studies have reported that the cleavage of Rand Roth, 1993). Mutant in7705-12a, within the viral-asso-
peptide from envelope TM (p15E) can activate the fusionciated cytoplasmic tail, was temperature sensitive (ts) in
of the SU/TM complex and the removal of R is essentialRat1 cells with decreased SU/TM on the virus particles
for infectivity (Ragheb and Anderson, 1994; Rein et al.,at the nonpermissive temperature and more efficient pro-
1994). These results imply a regulatory role of the R pep-teolytic processing of the R peptide than wild-type TM.
tide for fusion competence of the virus. The role of theMutant in7748-12a is within the R peptide and yielded
R peptide was further investigated using two linker inser-viable virus. In the present study, these mutants as well
tion mutations within the cytoplasmic domain of TM. Mu-as the Env R0 protein were further characterized and the
tation in7705-12a has a linker insertion within the cyto-ability to regulate fusion in NIH/3T3 cells was examined.
plasmic region which is maintained on the virus. in7748-
12a has the linker inserted within the R peptide (GrayMATERIALS AND METHODS
and Roth, 1993). For comparison, an Env R0 construct
was created by replacing 23 base pairs encoding the N-Cell lines and antibodies
terminus of the R peptide with a TAG stop codon at the
NIH/3T3, 293T (Pear et al., 1993), and XC cells were proteolytic site of cleavage.
grown in Dulbecco’s modified Eagle’s medium (GIBCO-
BRL) supplemented with 10% newborn calf-serum (Hy- Viral spread from an infectious provirus
clone). Anti-sera used include goat anti-Env serum (a-
SU), anti-Gag serum (a-CA) (79S000842 and 75S000287, The effect of these mutations on the virus viability was
analyzed by transfecting into Rat1 and NIH/3T3 cells therespectively, National Cancer Institute), and anti-p15E
monoclonal antibody 42-114 (a-TM) (Pinter et al., 1982). proviral genome containing each of the mutations at both
32 and 377 (Fig. 1). The viability of each mutation was
checked by reverse transcriptase assay (Goff et al.,Plasmids
1981). In NIH/3T3 cells, mutant Env R0 is positive for the
Plasmid pNCA-C (wild-type M-MuLV provirus; Colicelli release of reverse transcriptase (RT) at Day 11 at 377,
et al., 1985; Felkner and Roth, 1992) and linker insertion whereas at 327 it is positive by Day 22 (Fig. 1A, lanes 2
mutations in7705-12a and in7748-12a (Gray and Roth, and 7). Linker insertion mutants in7705-12a (lanes 3 and
1993) were previously described; numbering is based on 8) and in7748-12a (lanes 4 and 9) are viable at both
the M-MuLV RNA sequence (Shinnick et al., 1981). To temperatures in NIH/3T3 cells. In Rat1 cells, Env R0 is
eliminate expression of the R peptide, region 7724–7746 nonviable at both temperatures (Fig. 1B, lanes 2 and 7).
of MuLV was deleted and replaced with an in-frame TAG Cytoplasmic linker insertion mutant in7705-12a is tem-
stop codon and an EcoRI restriction site. The env gene perature sensitive in Rat1 cells (lanes 3 and 8), in agree-
was amplified by a polymerase chain reaction (PCR) ment with previously published results (Gray and Roth,
primed with oligonucleotides (2102) 5* GGCCAAACC- 1993). The linker insertion mutation within the R peptide
CCGTTCTG 3* (M-MuLV nucleotides 6582–6598) and called in7748-12a, (lane 4 and 9) spreads at levels com-
(5601) 5* ATGAATTCTATAGAGCCTGGACCACTGA 3*, parable to wild-type (lanes 5 and 10) at both tempera-
encoding a EcoRI restriction site (underlined) and stop tures.
codon (bold; complementary strand) and complementary
to M-MuLV positions 7706–7723. The PCR fragment Analysis of viral proteins
(1160 bp) was digested with restriction enzymes NsiI and
EcoRI and inserted into linker insertion mutant in7748- Viral particles were collected from both NIH/3T3 and
Rat1 cells expressing the mutant viral genomes, immuno-12a digested with NsiI and EcoRI, generating Env R0.
DNA sequencing confirmed the sequence to be CAG- precipitated with anti-CA, anti-SU, and anti-TM sera and
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Analysis of the wild-type TM protein (Fig. 2A, a-TM,
lanes 5 and 10) indicated the characteristic precursor
and proteolytically cleaved TM products. in7748-12a con-
tains four inserted amino acids in the R peptide and
results in a precursor protein which migrates characteris-
tically slower than the wild-type protein (Fig. 2A, a-TM,
lanes 4 and 9). Removal of the R peptide results in the
wild-type cleaved TM protein. In contrast, the linker inser-
tion within the cytoplasmic domain (in7705-12a) results
in the cleaved TM migrating characteristically slower
than the wild-type protein, due to the amino acid inser-
tions (Fig. 2A, a-TM, lanes 3 and 8). The precursor protein
is not detected, confirming the higher efficiency in the
cleavage reaction previously reported for this mutant.
Quite surprisingly, the Env R0 immunoprecipitated with
anti-TM resulted in not only the mature TM (p12E) pres-
ent on the viral particles (Fig. 2A, a-TM, lane 7) but also
the precursor TM similar to wild-type (lanes 5 and 10).
Since the Env R0 was generated by the insertion of a
stop codon, the precursor protein should not be synthe-
sized. This result indicates that mutant Env R0 has re-
verted to wild-type by the repair of the R peptide. The
delay in viral spread and the subsequent detection of
reverse transcriptase activity in the supernatant at Day
22 (Fig. 1A, lane 2), was due to this reversion event. The
shifted migration of TM in mutants in7705-12a (lanes 3
and 8) and in7748-12a (lanes 4 and 9) compared to wild
type verified that linker insertions in the cytoplasmic do-
main and the R peptide, respectively, are intact.
In Rat1 cells, the viral proteins were labeled on Day
28 of the dextran transfection (Fig. 2B). CA protein and
envelope proteins, SU and TM, are not detected in Env
R0 mutant at either temperature (panels 1–3, lanes 2
and 7) consistent with dextran transfection data showing
mutant Env R0 is nonviable in Rat1 cells. in7705-12a has
CA protein present at 327 but not at 377 (Fig. 2B, a-CA,FIG. 1. Time course of infection. Plasmid DNA expressing the individ-
lanes 3 and 8, respectively). Similarly, the SU and TMual env constructs were transfected into 105 Rat1 and NIH/3T3 cells
at 32 or 377, using the DEAE-dextran method (McCutchan and Pagano, proteins are only expressed at 327 (Fig. 2B, a-SU and a-
1968). The replication competence of the virus was assayed for the TM, lanes 3, respectively). Although the precursor protein
release of reverse transcriptase activity in the medium (Goff et al., is detected for in7705-12a in this experiment (Fig. 2B, a-
1981). (A) NIH/3T3 cells. (B) Rat1 cells. The individual constructs are
TM, lane 3), the efficiency of cleavage remains higherindicated above each lane. The temperature of growth of the cells is
than found for either the wild-type TM or the in7748-12aindicated above each lane. The number of days after introduction of
the DNA is indicated at the left of each panel. The panel is an exemplary mutant (Fig. 2B, a-TM, lanes 4 and 5, respectively). All
time course, which was repeated three times. three viral proteins are observed in mutant in7748-12a
at either temperature (Fig. 2B, lanes 4 and 9). The pres-
ence of the linker insertions within TM are readily detect-analyzed by SDS–PAGE. The capsid protein (CA) is en-
able in the precursor in7748-12a and the processedcoded by the gag gene and is representative of the level
in7705-12a forms (Fig. 2B, a-TM, lanes 3 and 4, respec-of viral particles. Virus release is known to occur inde-
tively), indicating that no reversion events had occurred.pendent of the envelope gene products. Viral proteins
from NIH/3T3 cells were labeled on Day 14 after the
transfection (Fig. 2A). CA and SU proteins are observed Expression of viral proteins from pHIT vectors
in all virus samples which were positive for reverse tran-
The ability of the cytoplasmic domain and R peptidescriptase activity. The lack of viral proteins for Env R0 at
to regulate fusion was examined by analyzing the forma-327 (Fig. 2A, lanes 2) is due to the delay in the viral
tion of large multinucleated syncytia in NIH/3T3 cells.spread, which was not readily detectable until Day 22
after the transfection. The mutants were originally expressed in a replication-
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FIG. 2. Expression of virus associated proteins. Cells were metabolically labeled, viral particles isolated, immunoprecipitated, and analyzed on
a SDS–PAGE as previously described (Felkner and Roth, 1992). (A) Virus isolated from NIH/3T3 cells, 14 days after transfection. (B) Virus isolated
from Rat1 cells, 28 days after transfection. The antisera used in the immunoprecipitations are indicated at the top of the lanes. The DNA used in
the transfections are indicated above each lane. The position of migration of the viral CA, SU, and TM proteins are indicated with an arrow at the
right side of the panel. The position of the molecular weight standards are indicated at the left of each panel. One-sixth of an extract from a 100-
mm plate was loaded on each lane.
competent MuLV allowing the passage of the virus high titers through expression in 293T cells. Briefly, three
expression plasmids, pHIT60 (gag-pol), pHIT111 (lac Z/through multiple rounds of infection. The evidence that
the Env R0 constructs readily reverted in NIH/3T3 cells neo), and pHIT123N (ecotropic env or mutant Env pHI-
TEnv R0, pHIT7705-12a, and pHIT7748-12a) with CMVnecessitated the use of expression vectors which were
limited to a single round of infection. The virus particles promoter and SV40 ori are transiently cotransfected into
293T cells expressing the SV40 large T antigen (Heinzelwere therefore assembled from a three-plasmid transient
transfection system (Soneoka et al., 1995) which yielded et al., 1988).
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FIG. 2— Continued
The expression of the env gene products in the three migration of pHIT7705-12a and pHIT7748-12a are char-
acteristically slower than pHIT123N. There is no evi-vector systems allows for the analysis of the Env proteins
dence of proteolytic processing or fortuitous breakdownin the presence and absence of the other viral proteins.
of the precursor yielding a product equivalent to the pro-This is of interest because the viral protease responsible
cessed form. For pHITEnv R0, the full-length precursorfor the cleavage of the R peptide is encoded in the pol
migrates, as expected with the size of the processed TMgene. Expression of only the Env proteins after transient
corresponding with the presence of the stop codon attransfection into 293T cells is shown in Fig. 3A. The full-
the site of proteolytic cleavage (lane 2). No TM productslength precursor protein is readily detected with the wild-
are detected without added exogenous DNA (lane 1).type M-MuLV env construct, pHIT123N (Fig. 3A, lane 5),
pHIT7748-12a (lane 4), and pHIT7705-12a (lane 3). The In the presence of the three plasmids, the proteolytic
AID VY 8333 / 6a22$$$622 12-15-96 20:14:39 vira AP: Virology
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FIG. 3. Expression of the intracellular TM proteins after transient transfection in 293T cells. 293T cells were labeled 48 hr posttransfection (40
min), followed by a 6-hr chase to allow transport and processing of the env gene products. (A) Transfection of the env expression vector (pHIT123
derivatives) alone (30 mg). (B) Transfection of the three plasmid system (10 mg/each plasmid) expressing env (pHIT123 derivative), gagpol (PHIT60),
plus a lacZ/neo vector (pHIT111). Extracts were immunoprecipitated with antibody 42-114 recognizing TM protein. The DNA used in the transfections
are indicated above each lane. The position of migration of the precursor and processed TM proteins are indicated with bracketed arrows at the
right side of the panel. The position of the molecular weight standards are indicated at the left of each panel. One-fourth of an extract from an 100-
mm plate was loaded on each lane.
TABLE 1cleavage of the TM can occur due to the expression
of the protease from the pHIT60 vector (Fig. 3B). The Syncytia Formation with NIH 3T3 Cells and XC Cells
processed forms of pHIT7705-12a, pHIT7748-12a, and
Number of syncytiathe wild-type control pHIT123N are detected (lanes 3, 4,
and 5, respectively). The migration of the precursor and
NIH 3T3 cells XC cellscleaved products are as predicted, indicating that no
reversion events have occurred during this limited time 377 327 377 327
of expression. The pHITEnv R0 product is not changed
pHITEnv R0 11,977 { 2,917 6,431 13,956 { 1,458 6,615by the presence of the protease, since the proteolytic
pHIT7705-12a 81 { 93 0 10,904 { 2,610 15,557cleavage site has been removed (lane 2). Although the
pHIT7748-12a 20 { 35 0 8,638 { 5,047 5,390extent of processing is less than found during intracellu-
pHIT123N 82 { 141 0 9,218 { 1,060 9,983
lar labeling from an infectious viral expression system, No DNA 0 0 45 { 67 0
the pHIT7705-12a Env proteins maintain a more efficient
Note. 293T cells (6 1 106/100 mM plate) were transfected with aproteolytic cleavage than the wild-type TM (compare Fig.
single Env expression plasmid (30 mg) as described (Soneoka et al.,3B, lanes 3 and 5).
1995). 48 hours posttransfection, cells were overlayed with the indi-
cated cells (1.2 1 106 cells) and stained 24 h later. The number of
Syncytia formation with NIH/3T3 cells and XC cells syncytia per 100-mm plate is indicated. Numbers represent average {
standard deviation; N  3.
The effect of each mutation on the ability to form syncy-
tia in NIH/3T3 cells and rat XC cells were examined.
Formation of the syncytia has been shown to be receptor viously reported (Ragheb and Anderson, 1994; Rein et
al., 1994), the Env R0 constructs formed syncytia withdependent (Ragheb, 1995). Since the 293T cells do not
express the ecotropic receptor ATRC 1, the receptor- NIH/3T3 cells. In contrast, the other mutants, pHIT7705-
12a and pHIT7748-12a, did not result in a significantpositive cells were overlaid on the 293T cells. Table 1
shows the results of expression of the envelope proteins number of syncytia (Table 1). The wild-type M-MuLV en-
velope did not fuse with NIH/3T3 cells (Jones and Risser,in the absence of the gag/pol gene products. As pre-
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TABLE 2 cells. All of the constructs maintained a high level of
fusion with the rat XC cells.Syncytia Formation from Virus Producer Cells
Number of syncytia (377) DISCUSSION
NIH 3T3 cells XC cells The experiments presented address the role of the
cytoplasmic tail of the M-MuLV TM protein, including thepHITEnv R0 18,029 { 3,101 15,836
R peptide to regulate the formation of syncytia and fusion.pHIT7705-12a 231 { 21 13,056
pHIT7748-12a 201 { 64 15,242 These findings confirm the earlier reports (Ragheb and
pHIT123N 1,146 { 1,027 14,128 Anderson, 1994; Rein et al., 1994) that in the absence of
No DNA 119 { 159 14 the R-peptide, TM results in fusion with NIH/3T3 cells
expressing the ecotropic virus receptor. The importanceNote. 293T cells were transfected with 10 mg of each pHIT60,
of maintaining the R peptide for the virus is evident bypHIT111, and pHITEnv plasmid. 48 hr posttransfection, cells were over-
layed with the indicated cells and stained 24 h later as described in the rapid reversion of the Env R0 construct in NIH/3T3
Table 1. The number of syncytia per 100-mm plate is indicated. Num- cells. Similar rapid reversion of R0 Env has been recently
bers represent averages { standard deviation; N  2. reported (Granowitz et al., 1996). The Env R0 constructs
were completely nonviable at both 32 and 377 in Rat1
cells, which contain less endogenous murine-like retrovi-
1993; Rein et al., 1994). The lack of syncytia formation ruses. The reversion detected in NIH/3T3 cells required
with the linker insertion mutations may be due to the the removal of the stop codon as well as the repair of
absence of envelope expression on the cellular mem- the deletion within the R peptide. We have also detected
brane. To examine this possibility, 293T cells were tran- a reversion of the in7705-12a mutation in NIH/3T3, re-
siently transfected with envelope mutants and overlaid sulting in a mixture of the mutant processed product
with XC cells. The results of XC assay indicate that all and the wild-type R minus form (data not shown). These
three mutants and the wild-type Env are fully competent results indicate a selective advantage for the virus which
in forming syncytia with XC cells. Therefore, envelope maintains the cytoplasmic tail and R peptide. The basis
proteins of linker insertion mutants are expressed on the for this selection is not understood and requires further
293T cells and the lack of syncytia formation with NIH/ investigation into the function of the R peptide.
3T3 cells is not due to the deficiency of envelope expres- The mutant in7705-12a addressed questions relating
sion on the cell surface. In addition, analysis of the viral to the temporal activation of fusion. in7705-12a displayed
proteins (Fig. 3A) has indicated that for pHIT7705-12a, enhanced cleavage of the R peptide. Although this con-
pHIT7748-12a, and the wild-type pHIT123N, only the pre- struct could result in near complete removal and pro-
cursor TM protein is made. This indicates the presence cessing of the R peptide, this did not result in the acti-
of the R peptide does not inhibit the formation of syncytia vated fusion with NIH/3T3 cells. Enhanced cleavage dur-
with rat XC cells. Although the in7705-12a was found ing the budding process did not result in the activation
to be ts for viral viability in Rat1 cells, no temperature of fusion with NIH/3T3 cells. This implies that activation
difference for XC syncytia formation was detected in 293T of the R minus form must occur prior to budding and may
cells. reflect an alternative assembly of the SU/TM-R minus
The ability of the Env proteins to form syncytia was multimer.
also determined in the presence of all of the viral proteins The presence of the R peptide did not regulate the
(Table 2). 293T cells were transfected with pHIT60, ability to form syncytia with rat XC cells. Transient trans-
pHIT111, and pHITEnv mutant and overlayed with either fection of the envelope proteins in the absence of the
NIH/3T3 or XC cells. This was of interest because the viral protease required for the removal of R peptide re-
in7705-12a mutant consistently indicated enhanced pro- sulted in the stable expression of the full-length precur-
teolysis of the R peptide. It was therefore possible that sor TM protein. These SU/TM proteins were fully compe-
the pHIT7705-12a TM would show activated fusion with tent to form large syncytia with XC cells in the presence
NIH/3T3 cells. The pHITEnv R0 protein showed activated of the R peptide. This adds to the evidence that syncytia
fusion with NIH/3T3 cells, 10- to 80-fold above the wild- formation with XC cells may involve an alternative path-
type Env. The level of fusion detected for pHIT7705-12a way for activation of fusion. Entry of ecotropic MuLV is
and pHIT7748-12a was, in general, below the level de- pH dependent, except for infection of Rat XC cells, where
tected for the wild-type control pHIT123N. This varied it is pH independent (McClure et al., 1990). Ecotropic
between 10-fold less than the wild-type control to back- MuLV form syncytia with XC cells, whereas amphotropic
ground levels of the 293T cells. However, these numbers MuLV do not. Analysis of chimeric ecotropic and ampho-
are small and the level of syncytia from the wild-type tropic MuLV has indicated that the domain of the env
MuLV is minimal. The increased processing of the R gene products responsible for the ability to form syncytia
with XC cells maps to the receptor binding domain ofpeptide did not result in increased fusion with NIH/3T3
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glycosylation sites of the SU envelope protein of Moloney murinethe ecotropic virus (Peredo et al., 1996; Ragheb et al.,
leukemia virus. J. Virol. 66, 4258–4264.1995). This implies that the domain of the SU/TM
Freed, E. O., and Martin, M. A. (1995). The role of human immunodefi-
multimer proposed to be required in fusion, namely the ciency virus type 1 envelope glycoproteins in virus infection. J. Biol.
TM protein, is not the trigger for the activated fusion with Chem. 270, 23883–23886.
Freed, E. O., and Martin, M. A. (1996). Domains of the human immuno-XC cells. The results presented in this paper extend this
deficiency virus type 1 matrix and gp41 cytoplasmic tail required forshowing the domain of TM proposed to regulate fusion
envelope incorporation into virions. J. Virol. 70, 341–351.(R) is not required for syncytia with XC cells.
Gallaher, W. R., Ball, J. M., Garry, R. F., Griffin, M. C., and Montelaro,
The mechanism by which R peptide regulates fusion R. C. (1989). A general model for the transmembrane proteins of HIV
is of interest and requires further definition. The Friend and other retroviruses. AIDS Res. Hum. Retroviruses 5, 431–440.
Goff, S. P., Traktman, P., and Baltimore, D. (1981). Isolation and proper-MuLV R peptide was able to regulate fusion when trans-
ties of Moloney murine leukemia virus mutants: Use of a rapid assayferred to the cytoplasmic 17 amino acid tail of the SIV
for release of virion reverse transcriptase. J. Virol. 38, 239–248.TM protein. One possibility is that the R peptide interacts
Granowitz, C., Colicelli, J., and Goff, S. P. (1991). Analysis of mutations
with either cellular proteins or the cytoplasmic tail of TM. in the envelope gene of Moloney murine leukemia virus: Separation
It has been proposed that the cytoplasmic tail of the of infectivity from superinfection resistance. Virology 183, 545–554.
Granowitz, C., Berkowitz, R. D., and Goff, S. P. (1996). Mutations affect-MuLV could form an amphipathic helix (Yang and Com-
ing the cytoplasmic domain of the Moloney murine leukemia viruspans, 1996). The linker-insertion in7705-12a is within this
envelope protein: Rapid reversion during replication. Virus Res. 41,putative amphipathic helix. Analysis of the potential helix
25–42.
with the four inserted amino acids indicates that the hy- Gray, K. D., and Roth, M. (1993). Mutational analysis of the envelope
drophobic face of the helix would be maintained, with a gene of Moloney murine leukemia virus. J. Virol. 67, 3489–3496.
Green, N., Shinnick, T. M., O. Witte, A. P., Sutcliffe, J. G., and Lerner,shift in orientation (data not shown). Studies of an amphi-
R. A. (1981). Sequence specific antibodies show that maturation ofpathic helix of HIV TM (gp41, amino acids 828–848) cyto-
Moloney leukemia virus envelope polyprotein involves removal of aplasmic tail suggested this region has the ability to inter-
COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78, 6023–6027.
act with cell membrane resulting in an increased mem- Henderson, L. E., Sowder, R., Copeland, T. D., Smythers, G., and
brane permeability (Chernomordik et al., 1994). The linker Oroszlan, S. (1984). Quantitative separation of murine leukemia virus
proteins by reversed-phase high pressure liquid chromatographywithin the potential amphipathic helix of M-MuLV region
reveals newly described gag and env cleavage products. J. Virol. 52,does not appear to interfere with its function.
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